1*Department of Epidemiology and Biostatistics, School of Public Health, Health Sciences University of Mongolia
2 Division of Virology, Department of Infection and Immunity, Jichi Medical University, Japan
Өгүүллийн PDF-ийг татах
WHO estimates 130-170 million (2-3 % of world population) people with hepatitis C viral infection in the World. Around 70% or 130 million of those with hepatitis C viral infection develop chronic forms with further progress to liver cirrhosis and liver carcinoma.1 Number of studies confirm the high prevalence of hepatitis C among Mongolian population.2,3,4 This study aimed to evaluate prevalence of hepatitis C virus (HCV) infection and its risk factors among population of Mongolia aged over 40. The results suggest that overall prevalence of HCV infection is 36.7%, prevalence among female is higher than male (p=0.0001). Risk factors related to medical procedures such as transfusion of blood and blood products, (OR=2.082, 95% CI 1.629-2.660), surgery (OR=1.289, 95% CI 1.087-1.529), injections (OR=1.4, 95% CI 1.093-1.893) were statistically significant risk factors.
